0001654954-19-005559.txt : 20190509
0001654954-19-005559.hdr.sgml : 20190509
20190509160727
ACCESSION NUMBER: 0001654954-19-005559
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190301
FILED AS OF DATE: 20190509
DATE AS OF CHANGE: 20190509
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DUNTON ALAN W
CENTRAL INDEX KEY: 0001304773
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34673
FILM NUMBER: 19810553
MAIL ADDRESS:
STREET 1: VICURON PHARMACEUTICALS INC
STREET 2: 455 S GULPH ROAD SUITE 305
CITY: KING OF PRUSSIA
STATE: PA
ZIP: 19406
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CorMedix Inc.
CENTRAL INDEX KEY: 0001410098
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 CONNELL DRIVE
STREET 2: SUITE 5000
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
BUSINESS PHONE: 908-517-9500
MAIL ADDRESS:
STREET 1: 400 CONNELL DRIVE
STREET 2: SUITE 5000
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
4/A
1
section16.xml
PRIMARY DOCUMENT
X0306
4/A
2019-03-01
2019-03-04
0001410098
CorMedix Inc.
CRMD
0001304773
DUNTON ALAN W
C/O CORMEDIX INC.
400 CONNELL DRIVE, SUITE 5000
BERKELEY HEIGHTS
NJ
07922
true
false
false
Stock Option (Right to Buy Common Stock)
8.50
2019-03-01
4
A
false
20000
0
A
2029-03-01
Common Stock
20000
20000
D
The vesting of the options was incorrectly reported in the original filing.
These options were granted on 3/1/2019. The options vest one-third on the date of grant, one-third on the first anniversary of the date of grant and one-third on the second anniversary of the date of grant.
The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split.
/s/ Alexander M. Donaldson, by power of attorney
2019-05-09